Novavax, Serum seek emergency use approval from WHO for Covid vaccine

Novavax, Serum seek emergency use approval from WHO for Covid vaccine

Novavax and SII made regulatory submissions to WHO for EUL of Novavax’s recombinant nanoparticle protein-based Covid-19 vaccine candidate with Matrix-M adjuvant.
Check the source here –Source, Financial Express.
Change Language